Works matching DE "CALCIUM antagonists"

Results: 4044
    1
    2
    3
    4
    5
    6
    7
    8

    Ефективність застосування інгібітора рецепторів ангіотензину-ІІ у собак за різних стадій міксоматозної дегенерації мітрального клапана (МДМК).

    Published in:
    Scientific Messenger of Lviv National University of Verterinary Medicine & Biotechnologies Series: Veterinary Sciences, 2024, v. 26, n. 116, p. 191, doi. 10.32718/nvlvet11628
    By:
    • Трофім’як, Р. М.;
    • Слівінська, Л. Г.
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Worsening migraine.

    Published in:
    Patient Care (Print), 2002, v. 36, n. 7, p. 76
    By:
    • Pinkowish, Mary Desmond;
    • Kelly, Roger E.
    Publication type:
    Article
    34

    Clinical Clips.

    Published in:
    Patient Care (Print), 2000, v. 34, n. 19, p. 134
    By:
    • Lobuono, Charlotte
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46

    Correction to: Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE Study

    Published in:
    2020
    By:
    • Imaizumi, Satoshi;
    • Shiga, Yuhei;
    • Ogawa, Masahiro;
    • Sako, Hideto;
    • Nagata, Yoshihisa;
    • Matsunaga, Akira;
    • Shirotani, Tetsuro;
    • Hoshino, Fumihiro;
    • Yahiro, Eiji;
    • Uehara, Yuko;
    • Morito, Natsumi;
    • Tanigawa, Hiroyuki;
    • Shimono, Dai;
    • Fukushima, Mikio;
    • Sugihara, Hidekazu;
    • Norimatsu, Kenji;
    • Kusumoto, Takaaki;
    • Saku, Keijiro;
    • Miura, Shin-ichiro
    Publication type:
    Correction Notice
    47

    Randomized trial of an increased dose of calcium channel blocker or angiotensin II type 1 receptor blocker as an add-on intensive depressor therapy in type 2 diabetes mellitus patients with uncontrolled essential hypertension: the ACADEMIE Study.

    Published in:
    Heart & Vessels, 2019, v. 34, n. 4, p. 698, doi. 10.1007/s00380-018-1286-2
    By:
    • Imaizumi, Satoshi;
    • Shiga, Yuhei;
    • Ogawa, Masahiro;
    • Sako, Hideto;
    • Nagata, Yoshihisa;
    • Matsunaga, Akira;
    • Shirotani, Tetsuro;
    • Hoshino, Fumihiro;
    • Yahiro, Eiji;
    • Uehara, Yuko;
    • Morito, Natsumi;
    • Tanigawa, Hiroyuki;
    • Shimono, Dai;
    • Fukushima, Mikio;
    • Sugihara, Hidekazu;
    • Norimatsu, Kenji;
    • Kusumoto, Takaaki;
    • Saku, Keijiro;
    • Miura, Shin-ichiro
    Publication type:
    Article
    48
    49
    50